About the company
We are using stem cells from own cord blood to treat brain damage in ~30,000 children in need per year (EU) that have been granted Orphan Drug Designation by EC_EMA(EU/3/16/1744). The enormous potential of the treatment was shown in ~400 children worldwide in the absence of major adverse events. Our treatment of brain damage in newborn infants is ready for clinical use and will enjoy EU monopoly for 12 years. So far we invested 4.5m €.
About the TeamAre you part of this team?
News about BrainRepair
Other Startups nearby
FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?